Ângela Fernandes

Ângela Fernandes

Auto-generated profile, based on publicly available information

Ângela Fernandes

1i3S – Institute for Research and Innovation in Health, University of Porto, Porto, Portugal

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Cellular Immunology
Verified
Journal Article
Open access
JRJoana G. Rodrigues
Joana G. Rodrigues
MBMeritxell Balmaña
Meritxell Balmaña
JMJoana A. Macedo
Joana A. Macedo
Juliana PoçasJuliana Poças
Juliana Poças
ÂFÂngela Fernandes
Ângela Fernandes
CRCelso Reis
Celso Reis
Tumour metastasis is the main cause of cancer related deaths. Metastasis is an intricate multi-step process that requires the acquisition of several cancer cell features, including the modulation of tumour cell migration, adhesion, invasion, and immune evasion. Changes in the cellular glycosylation are associated with malignant transformation of cancer cells, tumour progression and ultimately, metastasis formation. Glycans have major impact on cellular signalling and on the regulation of tumour cell-cell adhesion and cell-matrix interaction. Glycans drive the interplay between the cancer cells and the tumour microenvironment. In this review, we summarize the roles of glycan alterations in tumour progression, such as acquisition of oncogenic features due to modulation of receptor tyrosine kinases, proteoglycans, cadherins and integrins. We also highlight the importance of key glycan binding proteins such as selectins, siglecs and galectins, which are pivotal in the modulation of immune response. An overview on glycans as cancer biomarkers is also presented.

27 November 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MPMárcia S. Pereira
Márcia S. Pereira
IAInês Alves
Inês Alves
MVManuel Vicente
Manuel Vicente
ACAna Campar
Ana Campar
MSMariana C. Silva
Mariana C. Silva
SPSalomé Pinho
Salomé Pinho
The immune system is highly controlled and fine-tuned by glycosylation, through the addition of a diversity of carbohydrates structures (glycans) to virtually all immune cell receptors. Despite a relative backlog in understanding the importance of glycans in the immune system, due to its inherent complexity, remarkable findings have been highlighting the essential contributions of glycosylation in the regulation of both innate and adaptive immune responses with important implications in the pathogenesis of major diseases such as autoimmunity and cancer. Glycans are implicated in fundamental cellular and molecular processes that regulate both stimulatory and inhibitory immune pathways. Besides being actively involved in pathogen recognition through interaction with glycan-binding proteins (such as C-type lectins), glycans have been also shown to regulate key pathophysiological steps within T cell biology such as T cell development and thymocyte selection; T cell activity and signaling as well as T cell differentiation and proliferation. These effects of glycans in T cells functions highlight their importance as determinants of either self-tolerance or T cell hyper-responsiveness which ultimately might be implicated in the creation of tolerogenic pathways in cancer or loss of immunological tolerance in autoimmunity. This review discusses how specific glycans (with a focus on N-linked glycans) act as regulators of T cell biology and their implications in disease.

13 April 2022 in FEBS Letters
Verified
Journal Article
Closed access
IAInês Alves
Inês Alves
ÂFÂngela Fernandes
Ângela Fernandes
BSBeatriz Santos‐Pereira
Beatriz Santos‐Pereira
CACatarina M. Azevedo
Catarina M. Azevedo
SPSalomé Pinho
Salomé Pinho

1 April 2021 in Glycobiology
Verified
Journal Article
Closed access
TPTea Petrovic
Tea Petrovic
IAInês Alves
Inês Alves
DBdario bugada
dario bugada
JPJulio Pascual
Julio Pascual
FVFrano Vuckovic
Frano Vuckovic
Gordan LaucGordan Lauc
Gordan Lauc
A large variation in the severity of disease symptoms is one of the key open questions in coronavirus disease 2019 (COVID-19) pandemics. The fact that only a small subset of people infected with severe acute respiratory syndrome coronavirus 2 develops severe disease suggests that there have to be some predisposing factors, but biomarkers that reliably predict disease severity have not been found so far. Since overactivation of the immune system is implicated in a severe form of COVID-19 and the immunoglobulin G (IgG) glycosylation is known to be involved in the regulation of different immune processes, we evaluated the association of interindividual variation in IgG N-glycome composition with the severity of COVID-19. The analysis of 166 severe and 167 mild cases from hospitals in Spain, Italy and Portugal revealed statistically significant differences in the composition of the IgG N-glycome. The most notable difference was the decrease in bisecting N-acetylglucosamine in severe patients from all three cohorts. IgG galactosylation was also lower in severe cases in all cohorts, but the difference in galactosylation was not statistically significant after correction for multiple testing.

10 December 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
ÂFÂngela Fernandes
Ângela Fernandes
MAMaria M. Azevedo
Maria M. Azevedo
OPOlga Pereira
Olga Pereira
BSBelém Sampaio-Marques
Belém Sampaio-Marques
APArtur Paiva
Artur Paiva
Paula LudovicoPaula Ludovico
Paula Ludovico
Proteolytic systems and AMP-activated protein kinase are critical targets of acute myeloid leukemia therapeutic approaches

19 August 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
CACatarina M. Azevedo
Catarina M. Azevedo
BXBingxian Xie
Bingxian Xie
WGWilliam G. Gunn
William G. Gunn
RPRonal M. Peralta
Ronal M. Peralta
CDCarolina S. Dantas
Carolina S. Dantas
SPSalomé Pinho
Salomé Pinho
T-cell therapies have transformed cancer treatment. Although surface glycans have been shown to play critical roles in regulating T-cell development and function, whether and how the glycome influences T cell–mediated tumor immunity remains an area of active investigation. In this study, we show that the intratumoral T-cell glycome is altered early in human colorectal cancer, with substantial changes in branched N-glycans. We demonstrated that CD8+ T cells expressing β1,6-GlcNAc–branched N-glycans adopted an exhausted phenotype, marked by increased PD1 and Tim3 expression. CRISPR-Cas9 deletion of key branching glycosyltransferase genes revealed that Mgat5 played a prominent role in T-cell exhaustion. In culture-based assays and tumor studies, Mgat5 deletion in CD8+ T cells resulted in improved cancer cell killing. These findings prompted the assessment of whether MGAT5 deletion in anti-CD19 chimeric antigen receptor (CAR) T cells could enable this therapeutic modality in a solid tumor setting. We showed that MGAT5 knockout anti-CD19–CAR T cells inhibited the growth of CD19-transduced tumors. Together, these findings show that MGAT5-mediated branched N-glycans regulate CD8+ T-cell function in cancer and provide a strategy to enhance the antitumor activity of native and CAR T cells.